Catalent acquires Bettera Holdings from Highlander Partners


Catalent has acquired gummy, soft chew, and lozenge manufacturer Bettera Brands, from Highlander Partners.


Photo ©

Catalent Inc. (Somerset, NJ) has acquired Bettera Holdings LLC (Plano, TX), parent company of Bettera Brands, from Highlander Partners (Dallas, TX) for $1 billion. Bettera is a major manufacturer in the high-growth gummy, soft chew, and lozenge segments of the dietary supplement market. The company maintains four manufacturing operations in California, Virginia, New Jersey, and Indiana.

Bettera was formed by Highlander through a series of four acquisitions that began 2017. “In 2017, we started with a simple investment thesis of creating manufacturing capabilities around fortified/functional products in consumer-preferred formats," stated Jeff L. Hull, president and CEO of Highlander Partners, in a press release. "As consumers have become increasingly health-conscious, functional products in gummy, soft chew, and lozenge delivery forms have developed and grown to become a significant part of the market. Given the substantial advances in delivery technologies, along with the increased health awareness, consumers are embracing these experiential formats as part of their everyday wellness routine."

"As the leading global innovator of softgel and oral technologies, Catalent has a strong, long-standing presence in the rapidly expanding consumer health and nutraceutical marketplace. This acquisition allows us to significantly accelerate the growth of our consumer health business and offer customers access to the substantial potential in gummies, soft chews, and lozenges, which are all experiencing double-digit growth," commented Aris Gennadios, PhD, president, Softgel and Oral Technologies, Catalent. "This acquisition is a key strategic move for Catalent's Consumer Health business, where our leadership in manufacturing technologies and formulation can offer customers more product development opportunities and add manufacturing capacity in this dynamic and growing segment."

The transaction is expected to close by the end of 2021, subject to customary closing conditions.

Related Videos
woman working on laptop computer by window
© 2024 MJH Life Sciences

All rights reserved.